Market-Moving News for July 10th
$LGVN
$VRPX
$VVPR
Biotechnology: Pharmaceutical Preparations
Health Care
Biotechnology: Pharmaceutical Preparations
Health Care
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 12/6/2024 | $10.00 | Buy | ROTH MKM | |
| 1/5/2022 | $20.00 | Buy | EF Hutton |
4 - Longeveron Inc. (0001721484) (Issuer)
4 - Longeveron Inc. (0001721484) (Issuer)
4 - Longeveron Inc. (0001721484) (Issuer)
VivoPower to advise and support KWeather in procuring Ripple Lab shares, including some on its own balance sheet Balance of Ripple Lab shares held by VivoPower to be economically acquired by Lean Ventures VivoPower confirms it has not incurred any realized or unrealized losses on digital asset holdings VivoPower to receive $4.3million worth of KWeather shares representing 20% shareholding VivoPower to recycle profits and capital released to concentrate its focus and resources on its data center infrastructure strategy LONDON, Feb. 05, 2026 (GLOBE NEWSWIRE) -- VivoPower International PLC (NASDAQ:VVPR) ("VivoPower" or the "Company"), a leading B Corp-certified global developer and owner
The Mikaela Naylon Give Kids a Chance Act reauthorizes the Pediatric Priority Review Voucher (PPRV) Program and extends eligibility for medicines achieving U.S. FDA approval before September 2029The Pediatric Priority Review Voucher program encourages the development of treatments for rare pediatric diseasesU.S. FDA has awarded Longeveron's laromestrocel Hypoplastic Left Heart Syndrome (HLHS) program Rare Pediatric Disease designation, Orphan Drug designation, and Fast Track designationWith the extension of the PPRV Program, Longeveron may be granted a Priority Review Voucher if laromestrocel's Biological License Application (BLA) is approved by the FDA before September 2029 MIAMI, Feb. 05
VivoPower to advise and support KWeather in procuring Ripple Lab shares, including some on its own balance sheet Balance of Ripple Lab shares held by VivoPower to be economically acquired by Lean Ventures VivoPower to receive $4.3million worth of KWeather shares representing 20% shareholding VivoPower to concentrate its focus and resources on its data center infrastructure strategy LONDON, Feb. 04, 2026 (GLOBE NEWSWIRE) -- VivoPower International PLC (NASDAQ:VVPR) ("VivoPower" or the "Company"), a leading B Corp-certified global developer and owner of powered land and data center infrastructure for AI compute applications, confirms that it has completed a definitive agreement with Kwea
ROTH MKM initiated coverage of Longeveron with a rating of Buy and set a new price target of $10.00
EF Hutton initiated coverage of Longeveron with a rating of Buy and set a new price target of $20.00
6-K - VivoPower International PLC (0001681348) (Filer)
6-K - VivoPower International PLC (0001681348) (Filer)
6-K - VivoPower International PLC (0001681348) (Filer)
4 - Longeveron Inc. (0001721484) (Issuer)
4 - Longeveron Inc. (0001721484) (Issuer)
4 - Longeveron Inc. (0001721484) (Issuer)
Based in Dublin, Mr. Whelan is one of Europe's leading real estate and infrastructure asset developers He has multi-decade relationships with hyperscalers, including Google, Microsoft, and Amazon Development portfolio exceeds $2 billion in gross development value, spanning 3.5 million square feet Mr. Whelan will establish a Dublin office for VivoPower as it scales up its Sovereign AI data center infrastructure business, further advancing its Power -to-X strategy LONDON, UK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- VivoPower International PLC (NASDAQ:VVPR) ("VivoPower" or the "Company"), is pleased to announce the appointment of Shane Whelan to its Global Advisory Council. Mr. Whelan is a hi
Appointment further strengthens VivoPower's footprint across the Middle East, a priority growth region for the Company's Sovereign AI digital infrastructure and electric mobility platforms Based in the UAE for almost 18 years, Ms. Pether is highly reputed in both the DeFi and TradFi sectors Ms. Pether is the Head of Middle East at 3iQ, one of the world's largest digital asset managers, and a Senior Advisor to the Sovereign Wealth Fund Institute (SWFI); she was previously in a leadership position at Mubadala, one of the world's largest sovereign wealth funds LONDON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- VivoPower International PLC (NASDAQ:VVPR) ("VivoPower" or the "Company"), a leading B Cor
MIAMI, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions, today announced that George Paletta, Jr., MD, MBA, has been elected to the Longeveron Board of Directors. Dr. Paletta is a nationally and internationally recognized orthopedic surgeon and the head team doctor for the St. Louis Cardinals. Dr. Paletta is a developer of ambulatory surgical centers (ASCs), and has participated in the selling of two ASCs with deal values totaling almost $1 billion. "I am delighted to welcome George, and his tremendous experience as a physician, inv
MIAMI, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions, today announced that it will report third quarter 2025 financial results and provide a business update on Tuesday, November 4, 2025 after the U.S. financial markets close. The Company will host a conference call and webcast the same day at 4:30 p.m. ET. Conference Call and Webcast Details: Conference Call Number: 1.877.407.0789Conference ID: 13755997 Call me™ Feature: Click HereWebcast: Click Here An archived replay of the webcast will be available on the "Events & Presenta
MIAMI, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions, today announced that it will report second quarter 2025 financial results and provide a business update on Wednesday, August 13, 2025 after the U.S. financial markets close. The Company will host a conference call and webcast the same day at 4:30 p.m. ET. Conference Call and Webcast Details: Conference Call Number:1.877.407.0789Conference ID:13754295 Call meTM Feature:Click HereWebcast:Click Here An archived replay of the webcast will be available on t
Shareholders on record as of July 9, 2025, to receive five Caret Digital shares per VVPR share held Caret Digital subsidiary is to be spun off via a direct NASDAQ IPO at a target market capitalisation of US$308 million Negotiations are progressing with strategic pre-IPO investors in the Middle East and Asia for investment of up to US$50 million LONDON, June 24, 2025 (GLOBE NEWSWIRE) -- VivoPower International PLC (NASDAQ:VVPR, "VivoPower" or the "Company")) today announced that it has set the record date as July 9, 2025, for the purpose of determining eligibility to receive a special dividend relating to the spin-off of Caret Digital Limited ("Caret"). The implied market capitalisation
SC 13G/A - Longeveron Inc. (0001721484) (Subject)
SC 13G/A - VivoPower International PLC (0001681348) (Subject)
SC 13G/A - VivoPower International PLC (0001681348) (Subject)